CCL2 and neoplasm: In the development of cancer, tumor cells can attract regulatory immune cells (including regulatory T cell, tumor-associated macrophages) to the tumor microenvironment (TME), which is dominated by immunosuppressive myeloid cell types, through the production of immunosuppressive chemokines (such as CCL2) (Muenst et al., 2016).